Health officials involved in coronavirus vaccine clinical trials said that the drugs weren’t designed to stop the spread of COVID-19. The goal was to prevent severe COVID-19 cases and deaths. Preventing infection would >>
Health officials involved in coronavirus vaccine clinical trials said that the drugs weren’t designed to stop the spread of COVID-19. The goal was to prevent severe COVID-19 cases and deaths. Preventing infection would >>
As more contagious COVID variants spread across the US, Pfizer is exploring the utility of a third booster dose. Pfizer hopes that a third vaccine dose might “raise the antibody response 10 to >>
Pfizer is planning to deliver 200 million COVID vaccine doses to the US by May. Pfizer has managed to ramp up vaccine production significantly in recent weeks. Early on, Pfizer didn’t think it >>
A study from Israel indicates that people who received the Pfizer/BioNTech coronavirus vaccine develop an immune response significantly stronger than COVID-19 survivors. These researchers think this sort of immunity might completely prevent COVID-19 >>
The Pfizer coronavirus vaccine is even more effective than experts had hoped, according to interim data released earlier this week. Figures may change, but Pfizer seems to be on track to be the >>
HHS Secretary Alex Azar has given a rough outline regarding how and when the Pfizer vaccine to fight COVID-19 will start being distributed. In an interview with NBC’s TODAY show, Azar said among >>
The UK has accelerated the review of the three coronavirus vaccine frontrunners: AstraZeneca, Moderna, and Pfizer. The country’s government is conducting rolling reviews, which allow it to see data in real-time and potentially >>
Coronavirus vaccine candidate maker Pfizer was expected to release early efficacy results for Phase 3 in mid-October, ahead of the presidential election. That’s no longer the case, as the first efficacy data isn’t >>